Brynjelsen Sean

Eton Pharmaceuticals, Inc. · President & CEO

Brynjelsen Sean is listed in public filings as director, officer: President & CEO. This Brynjelsen Sean insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Eton Pharmaceuticals, Inc. (ETON). Investors use Brynjelsen Sean's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Eton Pharmaceuticals, Inc.ETON$27M833.8k sharesSellMay 28, 2026$3.8M119.9k shares$31.88--
Eton Pharmaceuticals, Inc.ETON$27M833.7k sharesSellMay 28, 2026$4.8K148 shares$32.67--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Eton Pharmaceuticals, Inc.ETON$47M3M sharesGrant / ExerciseJan 12, 2026$2.4M158k shares$15.47--
Eton Pharmaceuticals, Inc.ETON--3.1M sharesGrant / ExerciseJan 12, 2026Disclosure amount unavailable100.5k shares----
Eton Pharmaceuticals, Inc.ETON$44M2.9M sharesGrant / ExerciseJan 1, 2026$77.2K5k shares$15.39--
Eton Pharmaceuticals, Inc.ETON$49M2.9M sharesGrant / ExerciseDec 12, 2025$113.3K6.7k shares$16.83--
Eton Pharmaceuticals, Inc.ETON$48M2.9M sharesSellJun 5, 2025$1.2M70k shares$16.81--
Eton Pharmaceuticals, Inc.ETON$50M2.9M sharesSellJun 4, 2025$1.2M70k shares$17.00--
Eton Pharmaceuticals, Inc.ETON$53M3M sharesSellJun 3, 2025$1.1M60.9k shares$17.38--
Eton Pharmaceuticals, Inc.ETON$55M3M sharesSellJun 3, 2025$159.1K8.7k shares$18.38--
Eton Pharmaceuticals, Inc.ETON$57M3M sharesSellJun 3, 2025$7.6K400 shares$19.02--
Eton Pharmaceuticals, Inc.ETON$1.4M107.5k sharesGrant / ExerciseJan 3, 2025$1.4M107.5k shares$13.00--
Eton Pharmaceuticals, Inc.ETON--72k sharesGrant / ExerciseJan 3, 2025Disclosure amount unavailable72k shares----